540222:BOM
Laurus Labs Ltd
2 059,00 INR
arrow_upward
+1,93%(+39,00) 1D
16-окт., 15:59:49 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 540222...
Open
2 027,35 INR
High
2 086,00 INR
Low
2 027,35 INR
Mkt. cap
1,11 трлн
Avg. vol.
84,29 миң
Volume
103,13 миң
Dividend
0,10%
Quarterly dividend
0,50 INR
Ex-dividend date
2026-ж., 8-май
P/E ratio
101,80
52-wk high
2 086,00 INR
52-wk low
870,05 INR
EPS
20,23 INR
Shares outstanding
106,44 млн
No. of employees
7 миң
Open
2 027,35 INR
High
2 086,00 INR
Low
2 027,35 INR
Mkt. cap
1,11 трлн
Avg. vol.
84,29 миң
Volume
103,13 миң
Dividend
0,10%
Quarterly dividend
0,50 INR
Ex-dividend date
2026-ж., 8-май
P/E ratio
101,80
52-wk high
2 086,00 INR
52-wk low
870,05 INR
EPS
20,23 INR
Shares outstanding
106,44 млн
No. of employees
7 миң
News stories
From web sources and news partners
The Economic Times
·
1 күн мурун
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees7,06 миң
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitelauruslabs.com